A new predictor for type 2 diabetes?

CMAJ. Canadian Medical Association Journal

Volumn 178, Issue 3, 2008, Pages 313-315

  Sorisky, Alexander ^a,b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL FAT; ADIPOSE TISSUE; ADOLESCENCE; ADULTHOOD; BODY FAT; BODY FAT DISTRIBUTION; BODY MASS; CANADA; CARDIOVASCULAR DISEASE; CHILDHOOD; GOLD STANDARD; HIGH RISK POPULATION; HUMAN; INTRAABDOMINAL FAT; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; OBESITY; PREVENTIVE MEDICINE; SUBCUTANEOUS FAT; WAIST CIRCUMFERENCE;

EID: 38949131939     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.071679     Document Type: Note

References (19)

1. Lipscombe LL, Hux JE. Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study. Lancet 2007;369:750-6.
2. Déspres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006;444:881-7.
3. Lau DC, Douketis JD, Morrison KM, et al; Obesity Canada Clinical Practice Guidelines Expert Panel. 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. CMAJ 2007;176:S1-13.
4. Padwal RS, Majumdar SR. Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet 2007;309:71-7.
5. Haffner SM. Relationship of metabolic risk factors and development of cardiovascular disease and diabetes. Obesity (Silver Spring) 2006;14(Suppl 3):121S-7S.
6. Ray J, Mohllajee AP, van Dam RM, et al. Breast size and risk of type 2 diabetes. CMAJ 2008;3:289-95.
7. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444:860-7.
8. Hegele RA, Joy TR, Al-Attar SA, et al. Lipodystrophies: windows on adipose tissue biology and metabolism. J Lipid Res 2007;48:1433-44.
9. Danforth E Jr. Failure of adipocyte differentiation causes type II diabetes mellitus? Nature Genet 2000;26:13.
10. Heilbronn L, Smith SR, Ravussin E. Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type 2 diabetes mellitus. Int J Obes 2004;28:S12-21.
11. Miles JM, Jensen MD. Visceral adiposity is not casually related to insulin resistance. Diabetes Care 2005;28:2326-8.
12. Meigs JB, Wilson PWF, Fox CS, et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006;91:2906-12.
13. Karelis AD, Faraj M, Bastard JP, et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 2005;90:4145-50.
14. Shadid S, Koutsari C, Jensen MD. Direct free fatty acid uptake into human adipocytes in vivo: relation to body fat distribution. Diabetes 2007;56:1369-75.
15. Walker GE, Verti B, Marzullo P, et al. Deep subcutaneous adipose tissue: a distinct abdominal adipose depot Obesity (Silver Spring) 2007;15:1933-43.
16. Drife JO. Breast development in puberty. Ann N Y Acad Sci 1986;464:58-65.
17. Kusano AS, Trichopoulas D, Terry KL, et al. A prospective study of breast size and premenopausal breast cancer incidence. Int J Cancer 2006;118:2031-4.
18. Schernhammer ES, Tworoger SS, Eliassen AH, et al. Body shape throughout life and correlations with IGFs and GH. Endocr Relat Cancer 2007;14:721-32.
19. Rose DP, Haffner SM, Baillargeon J. Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women. Endocr Rev 2007;28:763-7.